Innovation in healthcare is crucial for the long-term viability of all communities.
BREEN Medical believes that bringing cutting edge medical technologies developed in leading research institutions to low- and middle-income country markets simultaneous to their deployment in established markets can offer both access to healthcare for underserved communities and create robust long term returns.
We look at every opportunity through the lens of the main health challenges the World Health Organisation (WHO) believes we will face over the decades to come which include:
Rising Burden of Non-Communicable Diseases (NCDs):
The WHO highlights the global rise in non-communicable diseases like cancer, chronic respiratory diseases, and diabetes as a major challenge. We believe there is great scope to address this burden through:
- Telehealth and remote patient monitoring tools to improve access to care and care management, including digital health platforms and mobile apps for lifestyle interventions, medication adherence, and preventive care.
- Personalised medicine approaches leveraging low-cost diagnostic tools and AI for early detection and targeted treatments.
Antimicrobial Resistance and Emerging Infectious Diseases:
The threat of new and resurgent infectious diseases, including potential future pandemics, is a pressing and ongoing concern. Diseases like COVID-19, HIV/AIDS, tuberculosis, malaria, and emerging viral diseases will continue to pose challenges globally, challenges that are exacerbated by climate change that brings pathogen vectors to new regions. The WHO also emphasises the urgent need to address the growing problem of antimicrobial resistance, which can render existing treatments for bacterial and viral infections ineffective, leading to increased morbidity and mortality.
Rapid advancements in vaccine development and manufacturing and improved disease surveillance and outbreak monitoring systems powered by AI will be essential to combat future outbreaks.
BREEN Medical also sees excellent opportunities for broad spectrum point-of-care diagnostic tools offering rapid and accurate detection of infectious diseases in remote or resource-limited settings, and broad-spectrum therapeutic devices to support the fight against infection and potentially provide alternatives to antimicrobials.
